Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 The associations among high IFN levels and SLE manifestations (stratified analyses of nominal regression models)

From: High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

  1. The analysis was run on 248 patients, in whom all four IFN measurements were available
  2. NPSLE neuropsychiatric SLE, LN lupus nephritis, ESR erythrocyte sedimentation rate, Hb haemoglobin, WBC white blood cells, PLT platelets, AVE any vascular event, aCL anti-cardiolipin, B2GP1 beta 2 glycoprotein 1, LA lupus anticoagulants, aPL antiphospholipid abs, U-alb/krea urine albumin kreatinine ratio
  3. *Definition by Systemic Lupus Activity Measure (SLAM)
  4. Definition by SLE Disease Activity Index (SLEDAI)
  5. ^Definition by 1982 ACR SLE classification criteria, if ever observed, disease damage was defined by SLE disease damage index (SDI)
  6. °p values based on Wald test